These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 22109647)
21. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Ying J; Srivastava G; Hsieh WS; Gao Z; Murray P; Liao SK; Ambinder R; Tao Q Clin Cancer Res; 2005 Sep; 11(18):6442-9. PubMed ID: 16166418 [TBL] [Abstract][Full Text] [Related]
22. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. Arnold CN; Goel A; Boland CR Int J Cancer; 2003 Aug; 106(1):66-73. PubMed ID: 12794758 [TBL] [Abstract][Full Text] [Related]
23. Re-expression of RASSF1A by 5-Aza-CdR induced demethylation of the promoter region in human biliary tract carcinoma cells. Zuo S; Chen Y; Xu L; Tang Q; Zou S J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):281-4. PubMed ID: 17641842 [TBL] [Abstract][Full Text] [Related]
24. [The study of 5-Aza-2'-deoxycytidine on transcription regulation of p16/CDKN2 gene demethylation in RKO human colorectal cell line]. Fang XM; Sun LF; Peng JP; Dong Q; Zheng S Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2077-82. PubMed ID: 14703421 [TBL] [Abstract][Full Text] [Related]
25. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma. Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391 [TBL] [Abstract][Full Text] [Related]
26. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma. Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919 [TBL] [Abstract][Full Text] [Related]
27. Epigenetic inactivation of RASSF1A in head and neck cancer. Dong SM; Sun DI; Benoit NE; Kuzmin I; Lerman MI; Sidransky D Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3635-40. PubMed ID: 14506151 [TBL] [Abstract][Full Text] [Related]
28. Pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to Pax5 Promoter Region. Liang Y; Zeng J; Jelicks L; Ma S; Liu J; Mei J; Perez-Soler R; Zou Y Curr Cancer Drug Targets; 2017; 17(2):169-176. PubMed ID: 27029827 [TBL] [Abstract][Full Text] [Related]
29. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594 [TBL] [Abstract][Full Text] [Related]
30. Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma. Wu W; Zhang L; Lin J; Huang H; Shi B; Lin X; Huang Z; Wang C; Qiu J; Wei X Oncotarget; 2016 Dec; 7(51):84416-84427. PubMed ID: 27793057 [TBL] [Abstract][Full Text] [Related]
31. Additive effects of 5-aza-2'-deoxycytidine and irradiation on clonogenic survival of human medulloblastoma cell lines. Patties I; Jahns J; Hildebrandt G; Kortmann RD; Glasow A Strahlenther Onkol; 2009 May; 185(5):331-8. PubMed ID: 19440673 [TBL] [Abstract][Full Text] [Related]
32. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells. Zhang J; Ling T; Wu H; Wang K J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482 [TBL] [Abstract][Full Text] [Related]
33. Association of RUNX3 Methylation with Clinical Outcome and Cell Migration/Invasion in Laryngeal Squamous Cell Carcinoma. Liu ZH; Liu JJ; Li SS; Yang XM Cancer Invest; 2016; 34(2):105-13. PubMed ID: 26853927 [TBL] [Abstract][Full Text] [Related]
34. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene. Tawfik HM; El-Maqsoud NM; Hak BH; El-Sherbiny YM Am J Otolaryngol; 2011; 32(6):528-36. PubMed ID: 21353335 [TBL] [Abstract][Full Text] [Related]
35. Enhancement of radiosensitivity by 5-Aza-CdR through activation of G2/M checkpoint response and apoptosis in osteosarcoma cells. Li Y; Geng P; Jiang W; Wang Y; Yao J; Lin X; Liu J; Huang L; Su B; Chen H Tumour Biol; 2014 May; 35(5):4831-9. PubMed ID: 24474250 [TBL] [Abstract][Full Text] [Related]
36. [Role of epigenetics in the carcinogenesis of head and neck carcinomas - possible new targeted therapy?]. Weber A; Dietz A; Tischoff I; Tannapfel A Laryngorhinootologie; 2007 Jan; 86(1):9-13. PubMed ID: 17226729 [TBL] [Abstract][Full Text] [Related]
37. [Demethylation of estrogen receptor gene and its re-expression in estrogen receptor-negative breast]. Wang R; Li LW; Wang RL; Fan QX; Zhao PR; Wang LX; Lu SH Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):894-7. PubMed ID: 17533738 [TBL] [Abstract][Full Text] [Related]
38. Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer. Peyser ND; Freilino M; Wang L; Zeng Y; Li H; Johnson DE; Grandis JR Oncogene; 2016 Mar; 35(9):1163-9. PubMed ID: 25982282 [TBL] [Abstract][Full Text] [Related]
39. Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor beta expression in head and neck squamous carcinoma (HNSCC) cells. Whang YM; Choi EJ; Seo JH; Kim JS; Yoo YD; Kim YH Cancer Chemother Pharmacol; 2005 Nov; 56(5):543-55. PubMed ID: 15959780 [TBL] [Abstract][Full Text] [Related]
40. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on P16, hMLH1 and MGMT genes and DNA methylation in human gastric cancer cells]. Meng CF; Zhu XJ; Dai DQ; Peng G Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):494-7. PubMed ID: 19742343 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]